Literature DB >> 25153512

Attenuation of lung cancer stem cell tumorigenesis and metastasis by cisplatin.

Shenxu Wang1,2, Sai Ma3, Xiujuan Li3, Zengfu Xue4, Xiaotian Zhang3, Weiwei Fan3, Yongzhan Nie4, Kaichun Wu4, Xiaoyuan Chen5, Feng Cao1,3.   

Abstract

PURPOSE: To investigate the effect of cisplatin on the growth and metastasis abilities of lung cancer stem cells (CSCs) via molecular imaging.
MATERIALS AND METHODS: The expression changes of lung CSCs cell marker in A549-Luc-C8 human non-small-cell lung cancer (NSCLC) cell line with or without cisplatin treatment were detected by flow cytometry. The tumorigenesis and metastasis abilities of A549-Luc-C8 cells were monitored both in vitro and in vivo, and the mechanism was assessed by gene sequencing.
RESULTS: About 1%-2% of CSCs were detected in A549-Luc-C8 cells and decreased CSCs percentage was observed after cisplatin treatment. Attenuated tumorigenesis and metastasis abilities of A549-Luc-C8 cells were found in cisplatin treated group.
CONCLUSIONS: Decreased percentage of CSCs in A549-Luc-C8 cells can be induced by cisplatin treatment, which may partly be attributed to the attenuated expression of growth factors.

Entities:  

Keywords:  cancer stem cells; cisplatin; growth factor; lung cancer; molecular imaging

Mesh:

Substances:

Year:  2014        PMID: 25153512      PMCID: PMC4564053          DOI: 10.3109/01902148.2014.938201

Source DB:  PubMed          Journal:  Exp Lung Res        ISSN: 0190-2148            Impact factor:   2.459


  48 in total

1.  Alteration on the expression of IL-1, PDGF, TGF-beta, EGF, and FGF receptors and c-Fos and c-Myc proteins in bone marrow mesenchymal stroma cells from advanced untreated lung and breast cancer patients.

Authors:  Erica Leonor Hofer; Vincent La Russa; Alba Elizabeth Honegger; Eduardo Oscar Bullorsky; Raúl Horacio Bordenave; Norma Alejandra Chasseing
Journal:  Stem Cells Dev       Date:  2005-10       Impact factor: 3.272

Review 2.  Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance.

Authors:  Karthika Natarajan; Yi Xie; Maria R Baer; Douglas D Ross
Journal:  Biochem Pharmacol       Date:  2012-01-11       Impact factor: 5.858

3.  Pivotal role of CD38 biomarker in combination with CD24, EpCAM, and ALDH for identification of H460 derived lung cancer stem cells.

Authors:  Feridoun Karimi-Busheri; Victoria Zadorozhny; Tony Li; Helen Lin; Daniel L Shawler; Habib Fakhrai
Journal:  J Stem Cells       Date:  2011

4.  Tumor necrosis factor-alpha enhances both epithelial-mesenchymal transition and cell contraction induced in A549 human alveolar epithelial cells by transforming growth factor-beta1.

Authors:  Yasuhiro Yamauchi; Tadashi Kohyama; Hajime Takizawa; Sumiko Kamitani; Masashi Desaki; Kazutaka Takami; Shin Kawasaki; Jun Kato; Takahide Nagase
Journal:  Exp Lung Res       Date:  2010-02       Impact factor: 2.459

5.  Expression of the potential cancer stem cell markers, CD133, CD44, ALDH1, and β-catenin, in primary lung adenocarcinoma--their prognostic significance.

Authors:  Koji Okudela; Tetsukan Woo; Hideaki Mitsui; Michihiko Tajiri; Munetaka Masuda; Kenichi Ohashi
Journal:  Pathol Int       Date:  2012-12       Impact factor: 2.534

6.  PET imaging of hepatocellular carcinoma with 2-deoxy-2[18F]fluoro-D-glucose, 6-deoxy-6[18F] fluoro-D-glucose, [1-11C]-acetate and [N-methyl-11C]-choline.

Authors:  N Salem; Y Kuang; F Wang; G T Maclennan; Z Lee
Journal:  Q J Nucl Med Mol Imaging       Date:  2008-11-28       Impact factor: 2.346

Review 7.  Antibodies targeting cancer stem cells: a new paradigm in immunotherapy?

Authors:  Mahendra P Deonarain; Christina A Kousparou; Agamemnon A Epenetos
Journal:  MAbs       Date:  2009 Jan-Feb       Impact factor: 5.857

8.  Drug-selected human lung cancer stem cells: cytokine network, tumorigenic and metastatic properties.

Authors:  Vera Levina; Adele M Marrangoni; Richard DeMarco; Elieser Gorelik; Anna E Lokshin
Journal:  PLoS One       Date:  2008-08-27       Impact factor: 3.240

Review 9.  Recent advances in cancer stem/progenitor cell research: therapeutic implications for overcoming resistance to the most aggressive cancers.

Authors:  M Mimeault; R Hauke; P P Mehta; S K Batra
Journal:  J Cell Mol Med       Date:  2007 Sep-Oct       Impact factor: 5.310

Review 10.  Lung cancer stem cells.

Authors:  Sharon R Pine; Blair Marshall; Lyuba Varticovski
Journal:  Dis Markers       Date:  2008       Impact factor: 3.434

View more
  1 in total

1.  The Metastasis Potential Promoting Capacity of Cancer-Associated Fibroblasts Was Attenuated by Cisplatin via Modulating KRT8.

Authors:  Xueqin Li; Qianqian Song; Xueru Guo; Limin Wang; Qicheng Zhang; Limin Cao; Yinghui Ren; Xiang Wu; Zhaowei Meng; Ke Xu
Journal:  Onco Targets Ther       Date:  2020-04-01       Impact factor: 4.147

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.